Murray Dallan — SEC Form 4 filings
SEC reporting owner CIK 2022303. 7 Form 4 filings on record with FilingPulse; latest filed 2025-03-11.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-06 to 2025-03-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,635 shares, $508,900 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 3,635 shares @ $140.00 ($508,900) in Sarepta Therapeutics, Inc., filed 2024-05-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | 7 | — | 1 leg · 3,635 sh · $508,900 | 18 |
Form 4 filings — Murray Dallan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 5,500 · Tax withholding (F): 996 @ $100.13 · Tax withholding (F): 2,737 @ $100.13 · Grant/award (A): 8,276 · Option exercise (M): 5,500 (derivative) @ $0 · Grant/award (A): 16,644 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 17,500 · Tax withholding (F): 549 @ $103.70 · Tax withholding (F): 8,613 @ $103.70 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,685 @ $101.34 | EDGAR |
| 2025-03-04 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 711 @ $103.77 | EDGAR |
| 2025-02-13 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 3,500 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 6,250 · Tax withholding (F): 2,352 @ $164.64 · Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Sale (S): 3,635 @ $140 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2022303 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →